Skip to Content

Clinical Trials Detail

GOG 0267: QUALITY OF LIFE AND CARE NEEDS IN PATIENTS WITH PERSISTENT OR RECURRENT PLATINUM-RESISTANT OVARIAN, FALLOPIAN TUBE, AND PERITONEAL CANCER

Objective
This is a clinical trial of quality of life and needs.
IRB Protocol Number
11-1319
Principal Investigator(s)
SUSAN DAVIDSON

Cancer Trials

  • Female Reproductive Cancer
Sponsor(s)
GOG
Contact
REBECCA KISSANE at 720-848-7202
or REBECCA.KISSANE@UCDENVER.EDU
Eligibility and Other Participant Information
What To Expect : A screening period to determine eligibility. A treatment period(s) that can last up to 6 months. A follow up period will consist of clinic visits. // Eligibility criteria include but are not limited to 18 years or older with advanced ovarian, fallopian tube, or peritoneal cancer.